1. BCRT: a brief valedictory

   • Marc Lippman

   Editorial 16 October 2019 Pages: 483 - 483

2. Obstetrical outcomes in women with history of breast cancer: a systematic review and meta-analysis

   • Valentina D’Ambrosio
   • Flaminia Vena
   • Antonella Giancotti

   Review 26 August 2019 Pages: 485 - 492

   

3. The microbiome and breast cancer: a review

   • Jennifer Chen
   • Jacqueline Douglass
   • Mehran Habibi

   Review 27 August 2019 Pages: 493 - 496

4. Prognostic value of receptor status conversion following neoadjuvant chemotherapy in breast cancer patients: a systematic review and meta-analysis

   • Chao Li
   • Hongwei Fan
   • Yimin Cui

   Review 30 August 2019 Pages: 497 - 504

   

5. Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie database

   • E. Kaczmarek
   • C. Saint-Martin
   • F. Lerebours

   Review 05 September 2019 Pages: 505 - 512

   

6. Home-based physical activity interventions for breast cancer patients receiving primary therapy: a systematic review

   • Steven S. Coughlin
   • Lee S. Caplan
   • Valerie Williams

   Review 06 September 2019 Pages: 513 - 522

   

7. Primary and secondary breast angiosarcoma: single center report and a meta-analysis

   • Yara Abdou
   • Ahmed Elkhanany
   • Mateusz Opyrchal

   Review Open access 14 September 2019 Pages: 523 - 533

   

8. CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy

   • Lutfi H. Alfarsi
   • Rokaya El Ansari
   • Andrew R. Green

   Preclinical study 30 August 2019 Pages: 535 - 544

   

9. Multiplex ddPCR assay for screening copy number variations in BRCA1 gene

   • Igor Oscorbin
   • Andrey Kechin
   • Maxim Filipenko

   Preclinical study 03 September 2019 Pages: 545 - 555

   

10. Germline investigation in male breast cancer of DNA repair genes by next-generation sequencing

    • R. Scarpitta
    • I. Zanna
    • M. A. Caligo

    Preclinical Study 11 September 2019 Pages: 557 - 564

    

11. CpG methylation signature predicts prognosis in breast cancer

    • Tonghua Du
    • Bin Liu
    • Yuanyu Wu

    Preclinical study 13 September 2019 Pages: 565 - 572

    

12. Cost-utility, cost-effectiveness, and budget impact of Internet-based cognitive behavioral therapy for breast cancer survivors with treatment-induced menopausal symptoms

    • Joost G. E. Verbeek
    • Vera Atema
    • Valesca P. Retèl

    Clinical trial Open access 26 August 2019 Pages: 573 - 585

    

13. Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing

    • W. Iris Zhi
    • Patricia Chen
    • Ting Bao

    Clinical trial 27 August 2019 Pages: 587 - 595

    

14. Radiological complete remission in HER2-positive metastatic breast cancer patients: what to do with trastuzumab?

    • T. G. Steenbruggen
    • N. I. Bouwer
    • G. S. Sonke

    Clinical trial 06 September 2019 Pages: 597 - 605

    

15. Long-term outcomes of breast-conserving therapy for women with ductal carcinoma in situ

    • Laura E. G. Warren
    • Yu-Hui Chen
    • Jennifer R. Bellon

    Clinical trial 06 September 2019 Pages: 607 - 615

16. Prophylactic acupuncture treatment during chemotherapy with breast cancer: a randomized pragmatic trial with a retrospective nested qualitative study

    • Benno Brinkhaus
    • Barbara Kirschbaum
    • Claudia M. Witt

    Clinical trial 13 September 2019 Pages: 617 - 628

    

17. Germline pathogenic variants in BRCA1, BRCA2, PALB2 and RAD51C in breast cancer women from Argentina

    • Roxana Cerretini
    • Graciela Mercado
    • Mohammad R. Akbari

    Epidemiology 24 August 2019 Pages: 629 - 636

    

18. Effectiveness of radiotherapy after breast-conserving surgery in older patients with T1-2N0 breast cancer

    • Anna Z. de Boer
    • Esther Bastiaannet
    • Gerrit Jan Liefers

    Epidemiology Open access 26 August 2019 Pages: 637 - 645

    

19. A population-based recurrence risk management study of patients with pT1 node-negative HER2+ breast cancer: a National Clinical Database study

    • Makoto Kubo
    • Masaaki Kawai
    • Hiromitsu Jinno

    Epidemiology Open access 26 August 2019 Pages: 647 - 656

    

20. Inherited variants in XRCC2 and the risk of breast cancer

    • Wojciech Kluźniak
    • Dominika Wokołorczyk
    • the Polish Hereditary Breast Cancer Consortium

    Epidemiology Open access 28 August 2019 Pages: 657 - 663

    

21. Validation of the online prediction model CancerMath in the Dutch breast cancer population

    • Liza A. Hoveling
    • Marissa C. van Maaren
    • Sabine Siesling

    Epidemiology 30 August 2019 Pages: 665 - 681

    

22. Analysis of incidence, mortality trends, and geographic distribution of breast cancer patients in Canada

    • François Lagacé
    • Feras M. Ghazawi
    • Ivan V. Litvinov

    Epidemiology 04 September 2019 Pages: 683 - 691

    

23. Optimal treatment of breast cancer in women older than 75 years: a Korea Breast Cancer Registry analysis

    • Ye Won Jeon
    • Sun Hyong You
    • Yong Seok Kim

    Epidemiology Open access 06 September 2019 Pages: 693 - 701

    

24. The impact of health symptoms on health-related quality of life in early-stage breast cancer survivors

    • K. M. de Ligt
    • M. Heins
    • S. Siesling

    Epidemiology Open access 11 September 2019 Pages: 703 - 711

    

25. Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism

    • Sora Yasri
    • Viroj Wiwanitkit

    Letter to the Editor 26 August 2019 Pages: 713 - 713

26. Acknowledgement of reviewers 2018

    Acknowledgments 04 October 2019 Pages: 715 - 727